IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 401 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $276,000 | +30.8% | 3,400 | -12.8% | 0.00% | 0.0% |
| Q4 2018 | $211,000 | +5.0% | 3,900 | 0.0% | 0.00% | +33.3% |
| Q3 2018 | $201,000 | -46.4% | 3,900 | -56.7% | 0.00% | -50.0% |
| Q2 2018 | $375,000 | +37.4% | 9,000 | +45.2% | 0.01% | +20.0% |
| Q1 2018 | $273,000 | -2.5% | 6,200 | +11.5% | 0.01% | 0.0% |
| Q4 2017 | $280,000 | +0.4% | 5,563 | +1.1% | 0.01% | 0.0% |
| Q3 2017 | $279,000 | -0.4% | 5,500 | 0.0% | 0.01% | -16.7% |
| Q2 2017 | $280,000 | +7.3% | 5,500 | -15.4% | 0.01% | +20.0% |
| Q1 2017 | $261,000 | -16.1% | 6,500 | 0.0% | 0.01% | -28.6% |
| Q4 2016 | $311,000 | +44.0% | 6,500 | +10.2% | 0.01% | +40.0% |
| Q3 2016 | $216,000 | -9.6% | 5,900 | 0.0% | 0.01% | -16.7% |
| Q1 2016 | $239,000 | -34.5% | 5,900 | 0.0% | 0.01% | -33.3% |
| Q4 2015 | $365,000 | – | 5,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |